Portal de investigación
- Inicio /
- Proyectos y Estudios /
- ESTUDIO FASE IIIB/IV, ABIERTO, CONTROLADO, ALEATORIZADO EN GRUPOS PARALELOS PARA COMPARAR LA EFICACIA EN LA CURACIÓN CLÍNICA SOSTENIDA DEL TRATAMIENTO CON VANCOMICINA FRENTE AL TRATAMIENTO DE DURACIÓN EXTENDIDA DE FIDAXOMICINA EN PACIENTES ANCIANOS QUE PRESENTAN UNA INFECCIÓN POR CLOSTRIDIUM DIFFICILE.
ESTUDIO FASE IIIB/IV, ABIERTO, CONTROLADO, ALEATORIZADO EN GRUPOS PARALELOS PARA COMPARAR LA EFICACIA EN LA CURACIÓN CLÍNICA SOSTENIDA DEL TRATAMIENTO CON VANCOMICINA FRENTE AL TRATAMIENTO DE DURACIÓN EXTENDIDA DE FIDAXOMICINA EN PACIENTES ANCIANOS QUE PRESENTAN UNA INFECCIÓN POR CLOSTRIDIUM DIFFICILE.
Datos básicos
- Código:
- 2819-MA-1002
- Protocolo:
- 2819-MA-1002
- EUDRACT:
- 2013-004619-31
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2014
- Año de finalización:
Documentos
- No hay documentos
Participantes
-
Sandra Cuéllar Tovar
Data Manager / Study Coordinator
-
Miguel Salavert Lletí
Investigador Principal
Grupos
-
Infección Grave
Investigador Principal
María Ángeles Tormo Mas
Financiadores - Promotores
Resultados del Ensayo Clínico
INVESTIGACIÓN Y FORMACIÓN EN MEDICINA INTENSIVA
ÁLVARO CASTELLANOS ORTEGA, PAULA RAMÍREZ GALLEYMORE
Capítulo de un Libro. 2017
[Farewell open letter to SEFH members].
Editorial Material. 10.7399/fh.2015.39.6.10128. 2015
[Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].
Estella, Angel; (...); Zaragoza, Rafael
Article. 10.1016/j.medin.2021.04.007. 2021
[Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units].
Vidal-Cortes, Pablo; (...); Crespo, Rafael Zaragoza
Article. 10.1016/j.medin.2021.08.011. 2021
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A clinical predictive model of candidemia by Candida auris in previously colonised critically ill patients.
Garcia-Bustos V; (...); Pemán J
Article. 10.1016/j.cmi.2020.02.001. 2020
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.
Cuervo G; (...); Validation Cohort Project
Article. 10.1016/j.cmi.2015.02.029. 2015
A surface plasmon resonance based approach for measuring response to pneumococcal vaccine.
Garrido-Jareño M; (...); Pineda-Lucena A
Article. 10.1038/s41598-021-85958-0. 2021
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimc.2021.05.009. 2021
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimce.2021.05.020. 2023
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Article. 10.1038/tpj.2015.80. 2016
A young patient with fever after heart transplantation
Ramos, A; (...); Bouza, E
Editorial Material. 2018
Acceptance and validity of the methods used to implement a competency based medical education programme in an Intensive Care Department of a teaching referral center.
Castellanos-Ortega, A.; (...); Garcia-Ros, R.
Article. 10.1016/j.medin.2019.12.007. 2021
Acceptance and validity of the methods used to implement a competency based medical education programme in an Intensive Care Department of a teaching referral center.
Castellanos-Ortega A; (...); García-Ros R
Article. 10.1016/j.medine.2019.12.011. 2021
Actinotignum schaalii infection: Challenges in diagnosis and treatment.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1016/j.heliyon.2024.e28589. 2024
Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach
de la Peña-Moral JM; (...); Parrilla P
Article. 10.1111/hepr.12369. 2015
ACUTE PARAPARESIS AS CLINICAL PRESENTATION OF VERTEBRAL OSTEOMYELITIS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6662. 2019
Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain.
Ramírez P; (...); Castellanos Á
Article. 10.1016/j.medin.2020.06.015. 2021
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Adoptive transfer of ex-vivo expanded SARS-CoV-2-specific Cytotoxic Lymphocytes: a viable strategy for COVID-19 immunosuppressed patients?
Guerreiro M; (...); Piñana JL
Article. 10.1111/tid.13602. 2021
Aflibercept in exudative age related macular degeneration refractory to ranibizumab.
Ruiz Ramos J; (...); Gallego-Pinazo R
Article. 10.1016/j.oftal.2015.07.018. 2015
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C; (...); Garcia-Vidal, C
Article. 10.1093/jac/dkz491. 2020
An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital
Ruiz-Gaitan, A; (...); Peman, J
Article. 10.1111/myc.12781. 2018
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Analysis of treatment failure with standardand high dose of tigecycline in critically ill patients with multidrug resistant bacteria.
JESÚS RUIZ RAMOS; (...); PAULA RAMÍREZ GALLEYMORE
Article. 2017
Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy
Mensa, J; (...); Oliver, A
Article. 2018
Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.
Villarreal, E.; (...); Vila, J.
Article. 10.1016/j.medine.2022.04.019. 2022
Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.
Ruiz-Ramos, Jesus, Gras-Martin, Laura, Ramirez, Paula
Article. 10.3390/antibiotics12030475. 2023
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
Cercenado, Emilia; (...); Retamar-Gentil, Pilar
Practice Guideline. 10.1016/j.eimce.2022.05.013. 2023
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP
Cercenado, Emilia; (...); Retamar-Gentil, Pilar
Editorial Material. 10.1016/j.eimc.2022.05.005. 2023
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
Antimicrobial stewardship programs in the critical care setting
Ruiz-Ramos J, Ramirez P
Editorial Material. 10.1016/j.medin.2016.04.010. 2016
Antimicrobial stewardship programs in the intensive care unit in patients with infections caused by multidrug-resistant gram-negative bacilli
Ramos, J. Ruiz, Galleymore, P. Ramirez
Article. 10.1016/j.medin.2022.07.007. 2023
Antimicrobial stewardship programs in the Intensive Care Unit in patients with infections caused by multidrug-resistant Gram-negative bacilli.
Ruiz-Ramos J, Ramírez P
Article. 10.1016/j.medine.2022.09.004. 2022
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum beta-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015)
Canton, R; (...); SMART Spain Working Grp
Article. 2018
Antisepsis for blood culture extraction. Blood culture contamination rate
Galleymore, PR, Sahuquillo, MG
Article. 10.1016/j.medin.2018.08.007. 2019
Are migrants acquiring HIV before or after migration to Spain? Results from the aMASE study
Alvarez-del Arco, D; (...); del Amo, J
Meeting Abstract. 2017
ASSESMENT OF CLINICAL AND RADIOLOGICAL PROGNOSTIC VARIABLES IN PATIENTS WITH SPONDYLODISCITIS
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5891. 2017
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Assessment of the quality of sample labelling for clinical research.
Pérez-Huertas P; (...); Poveda-Andrés JL
Article. 10.7399/fh.2016.40.2.9753. 2016
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Bacteraemia and infection of the vascular catheter in the haematology patient: positioning and management based on the Delphi method
Azanza-Perea, JR; (...); Rivas-Gonzalez, P
Article. 2016
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
Beyond the Pandemic: The Value of Antimicrobial Stewardship
Kanj, Souha S., Ramirez, Paula, Rodrigues, Camilla
Article. 10.3389/fpubh.2022.902835. 2022
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study
Póvoa P; (...); Artigas A
Article. 10.1186/s13613-016-0134-8. 2016
Biomarkers As Predictors Of Early And Long-Term Cardiovascular Events In Community-Acquired Pneumonia. Preliminary Results
Mendez, R.; (...); Menendez, R.
Meeting Abstract. 2016
Biomarkers in pulmonary infections: a clinical approach.
Povoa, Pedro; (...); Kalil, Andre C
Article. 10.1186/s13613-024-01323-0. 2024
Biomarkers in the ICU: less is more? Yes.
Huang, David T., Ramirez, Paula
Editorial Material. 10.1007/s00134-020-06049-8. 2021
Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study
Povoa, P; (...); Artigas, A
Article. 10.1016/j.jcrc.2017.05.007. 2017
Biomarkers of fungal infection: Expert opinion on the current situation
Bouza, E; (...); Sanguinetti, M
Review. 10.37201/req/2260.2019. 2020
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population
Perez-Huertas, P; (...); Poveda-Andres, JL
Article. 10.1177/1043454216631952. 2017
Blood culture contamination rate in an intensive care setting: Effectiveness of an education-based intervention
Ramirez P; (...); Bonastre J
Article. 10.1016/j.ajic.2015.04.183. 2015
Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen
Article. 10.1016/j.bbmt.2014.12.038. 2015
Boosted protease inhibitor monotherapy in HIV-infected patients: results of a study in a real life setting
Di Benedetto N; (...); Salavert M
Article. 2015
Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience
Garcia-Robles, AA; (...); Fernandez-Navarro, JM
Meeting Abstract. 2017
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rodriguez-Leal, Cristobal M.; (...); Salavert, Miguel
Review. 10.37201/req/018.2024. 2024
Candidemia in major burns patients
ANA ISABEL RENAU ESCRIG; (...); Pemán J
Article. 10.1111/myc.12488. 2016
Candidemia in non-ICU surgical wards: Comparison with medical wards
Vena, Antonio; (...); CANDIPOP Project
Article. 10.1371/journal.pone.0185339. 2017
Candidemia in solid organ transplant recipients in Spain: epidemiological trends and determinants of outcome.
Fernández-Ruiz M; (...); Aguado JM
Article. 10.1111/tid.13195. 2019
Capnophilic Enterobacteriaceae
Sahuquillo-Arce, JM; (...); Lopez-Hontangas, JL
Article. 10.1016/j.diagmicrobio.2017.01.010. 2017
Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla(VIM-2), bla(VIM-1), bla(IMP-8), bla(VIM-20) and bla(KPC-2)
Perez-Vazquez, M; (...); Oteo-Iglesias, J
Article. 10.1016/j.ijantimicag.2020.106026. 2020
Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2
Arana, DM; (...); Spanish Antibiotic Resistance Surveillance Programme Collaborating Group
Article. 10.1093/jac/dkx325. 2017
Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.
Marín-Cerezuela M; (...); Ramirez P
Letter. 10.1186/s13054-024-05126-4. 2024
Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.
Martin-Cerezuela, M; (...); Galleymore, P R
Article. 10.1016/j.medin.2021.05.011. 2021
Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.
Martín-Cerezuela M; (...); Galleymore PR
Article. 10.1016/j.medine.2021.05.007. 2022
Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study.
Babich T; (...); Yahav D
Article. 10.1093/cid/ciz668. 2020
Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort.
Hidalgo-Tenorio, Carmen; (...); Sadyrbaeva-Dolgova, Svetlana
Article. 10.3390/antibiotics12071218. 2023
Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia.
Ruiz J; (...); Ramirez P
Article. 10.1177/1559325819885790. 2020
Central nervous system infections in immunocompromised patients
Castro, I; (...); Salavert, M
Article. 2018
Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.
Garcia-Bustos, Victor; (...); Peman, Javier
Article. 10.1016/j.cmi.2023.03.016. 2023
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry
Madero Velazquez, L.; (...); Gutierrez-Casbas, A.
Meeting Abstract. 2024
Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study
Pinana, JL; (...); Navarro, D
Article. 10.1093/cid/ciy792. 2019
Clinical evaluation of rituximab treatment for neuromyelitis optica
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.nrl.2014.09.001. 2015
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
Ferrer, Ricard; (...); McCann, Eilish
Article. 10.37201/req/096.2021. 2021
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens.
Piñana JL; (...); Navarro D
Letter. 10.1016/j.jinf.2020.01.001. 2020
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007. 2023
CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.
Article. 10.1016/j.jtct.2024.01.082. 2024
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial
Cisneros, JM; (...); Magic Bullet Working Grp WP1
Article. 10.1186/s13054-019-2627-y. 2019
Collaborative model of home delivery program in haemophilia through an association of patients
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program
Montero JG; (...); García MS
Review. 10.1186/s13054-015-0800-5. 2015
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich, T; (...); Yahav, D
Article. 10.1093/jac/dkab134. 2021
Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
De La Puerta R; (...); Piñana JL
Article. 10.1038/s41409-021-01319-5. 2021
Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.
Montoro J; (...); Piñana JL
Article. 10.1038/s41409-020-0943-0. 2020
Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections
Pinana, JL; (...); Navarro, D
Article. 10.1111/tid.12926. 2018
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019
Consensus opinion on antifungal prophylaxis in haematologic patients: Results of the PROMIC project
Vazquez Lopez, Lourdes; (...); Camps, IR
Article. 2017
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
Monzó-Gallo P; (...); Garcia-Vidal C
Correction. 10.1016/j.ijid.2024.107188. 2024
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
Salavert, M; (...); Grau, S
Article. 10.1007/s12325-018-0813-y. 2018
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1080/13696998.2017.1311903. 2017
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.
Grau S; (...); Rubio-Terrés C
Article. 10.2147/CEOR.S91587. 2015
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT
Fragio-Gil, J. J.; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Current approach to skin and soft tissue infections. Thinking about continuity of care.
Blanes Hernández R; (...); Salavert Lletí M
Article. 10.37201/req/s01.10.2023. 2023
Current aspects in sepsis approach. Turning things around
Javier Candel, Francisco; (...); Vidal, Pablo
Review. 2018
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
Garcia-Bustos, Victor; (...); Blanes, Marino
Article. 10.37201/req/s03.16.2022. 2022
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.
Vidal-Cortes, Pablo; (...); Zaragoza, Rafael
Review. 10.3390/antibiotics11091160. 2022
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1186/s13071-020-3901-1. 2020
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.
Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina
Article. 10.1093/mmy/myac038. 2022
Cytomegalovirus DNA load monitoring in stool specimens for anticipating the occurrence of intestinal acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: Is it of any value?
Bueno F; (...); Navarro D
Article. 10.1111/tid.13440. 2020
Cytomegalovirus DNAemia in hematological patients undergoing CD19-directed CAR-T cell therapy: should it be systematically monitored?
Solano de la Asuncion, Carlos; (...); Navarro, David
Letter. 10.1016/j.cmi.2023.05.010. 2023
Challenges in Clinical Metaproteomics Highlighted by the Analysis of Acute Leukemia Patients with Gut Colonization by Multidrug-Resistant Enterobacteriaceae
Rechenberger, J; (...); Kuster, B
Article. 10.3390/proteomes7010002. 2019
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; (...); Pemán J
Article. 10.1128/Spectrum.00013-21. 2021
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
Asensi, V; (...); Pineda, JA
Article. 10.1371/journal.pone.0221598. 2019
Choice of treatment in Clostridium difficile-associated diarrhoea: Clinical practice guidelines or risk classifications
Editorial Material. 10.1016/j.eimc.2017.11.004. 2017
Chronic pain and a single lesion in the distal radius
Di Benedetto N; (...); Salavert M
Editorial Material. 10.1016/j.eimc.2014.11.011. 2015
Daily bathing strategies and cross-transmission of multidrug-resistant organisms: Impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1016/j.ajic.2017.06.029. 2017
Dalbavancin in clinical practice in Spain: a 2 year retrospective study.
Morata, Laura; (...); Almirante, Benito
Article. 10.1093/jacamr/dlac120. 2022
Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study.
Morata Ruiz L; (...); Grossi PA
Article. 10.1016/j.jgar.2023.11.015. 2024
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
Shaw E; (...); Instituto de Salud Carlos III, Madrid, Spain
Article. 10.1136/bmjopen-2014-006723. 2015
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
Canton, Rafael; (...); Gonzalez del Castillo, Juan
Article. 10.37201/req/172.2021. 2022
Decolonization strategies against multidrug resistant organisms in the ICU.
Póvoa P, Ramirez P, Blot S
Editorial Material. 10.1007/s00134-024-07360-4. 2024
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Blade, J; (...); Lizan, L
Article. 10.1136/bmjopen-2017-018850. 2018
Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients
Vazquez, L; (...); Study Grp Risk Factors IFI Using
Article. 2017
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients
Ruiz-Gaitan, Alba; (...); Peman, Javier
Article. 10.1080/14787210.2019.1592675. 2019
Detection of plasmid-mediated colistin resistance, mcr-1 gene, in Escherichia coli isolated from high-risk patients with acute leukemia in Spain
Lalaoui, R; (...); Rolain, JM
Article. 10.1016/j.jiac.2019.03.007. 2019
Determination of meropenem in endotracheal tubes by in-tube solid phase microextraction coupled to capillary liquid chromatography with diode array detection
Hakobyan, L; (...); Campins-Falco, P
Article. 10.1016/j.jpba.2018.01.006. 2018
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).
Chaves F; (...); Valles J
Article. 10.1016/j.medin.2017.09.012. 2018
Diagnostico microbiologico de las hepatitis virales.
Alonso R; (...); Fuertes A
Article. 10.1016/j.eimc.2014.08.002. 2015
DIFFERENTIAL MOLECULAR DIAGNOSIS OF UTERINE LEIOMYOMAS AND LEIOMYOSARCOMAS USING DNA AND RNA SEQUENCING
Mas, A.; (...); Simon, C.
Meeting Abstract. 10.1136/ijgc-2019-ESGO.120. 2019
Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis.
Asensi Cantó P; (...); Guerreiro M
Article. 10.1111/tid.14067. 2023
Distal Access Catheter Improves Balloon Guide and Stent Retriever Thrombectomy Outcomes in Nonagenarians.
Puig, Josep; (...); Blasco, Jordi
Article. 10.1111/jon.70012. 2025
Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.
Castro I; (...); Salavert M
Article. 2019
Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
Garcia-Bustos, V; (...); Munoz, EC
Editorial Material. 10.3389/fcimb.2021.671962. 2021
Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.
Pérez Huertas P; (...); Poveda Andrés JL
Article. 10.7399/fh.2015.39.4.8839. 2015
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Babich T; (...); Yahav D
Article. 10.1007/s40121-022-00657-1. 2022
Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon, Marta Dafne; (...); Carda-Dieguez, Miguel
Article. 10.1016/j.clim.2023.109796. 2023
Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases
Megias-Vericat, JE; (...); Poveda, JL
Review. 10.1007/s10072-017-2833-9. 2017
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Moreno-Garcia, E; (...); Garcia-Vidal, C
Article. 10.1093/ofid/ofab250. 2021
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
Rubio-Terrés C; (...); Gani R
Article. 10.1007/s10096-015-2472-0. 2015
Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study
Bouza, E; (...); Limon, E
Article. 10.37201/req/135.2020. 2021
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan
Ribera, E; (...); Hernandez-Novoa, B
Article. 10.1016/j.eimc.2016.11.015. 2018
Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis
Cuervo G; (...); Carratalà J
Article. 10.1093/cid/cix033. 2017
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
Effect of freezing and storage temperature on stability and antimicrobial activity of an antibiotic mixture used for decontamination of tissue allografts
Mirabet, V; (...); Gimeno, C
Article. 10.1007/s10561-018-9693-2. 2018
Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1177/2050312120958897. 2020
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Efficacy and Experience of Bacteriophages in Biofilm-Related Infections.
Gordon, Monica, Ramirez, Paula
Article. 10.3390/antibiotics13020125. 2024
eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Megias-Vericat, JE
Meeting Abstract. 2018
Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS.
Pérez-Vázquez M; (...); Spanish NDM Study Group
Article. 10.1093/jac/dkz366. 2019
EPICO 3.0. Management of non-neutropenic patients in medical wards
Ferrer, R; (...); Huarte, R
Article. 10.1016/j.riam.2016.06.003. 2016
EPICO 3.0. Management of non-neutropenic patients in medical wards (vol 33, pg 216, 2016)
Ferrer, R; (...); Huarte, R
Correction. 10.1016/j.riam.2017.02.004. 2017
Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020
Lozano, Noelia; (...); Calabuig, Eva
Article. 10.1016/j.actatropica.2024.107458. 2024
Epidemiology and clinical features caused by Candida auris in the setting of a prolonged outbreak
Meeting Abstract. 2017
Epidemiology and prognosis of candidaemia in elderly patients
Ramos-Martinez, A; (...); Members of the CANDIPOP Project from GEIH-GEMICOMED (SEIMC) and REIPI
Article. 10.1111/myc.12677. 2017
Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.
Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor
Article. 10.37201/req/s01.20.2022. 2022
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Evaluating the diagnostic performance of Liaison® chemiluminescence assay as screening tool for detection of acute Epstein-Barr infection: A comparative study
Tortosa-Carreres, Jordi; (...); Lopez-Hontangas, Jose Luis
Article. 10.1016/j.diagmicrobio.2023.116167. 2024
Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia.
Ceccato, Adrian; (...); Artigas, Antonio
Article. 10.3390/biomedicines11102676. 2023
Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)
Chaves, F; (...); Valles, J
Article. 10.1016/j.eimc.2017.10.019. 2018
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
Experience of Home Delivery Program in Haemophilia Through an Association of Patients
Megias Vericat, J. E.; (...); Bonanad Boix, S.
Meeting Abstract. 2017
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY
Paz S; (...); Urcelay J
Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
Extended-pulsed fidaxomicin versus vancomycin in patients 60years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
Rubio-Terres, C; (...); Rubio-Rodriguez, D
Article. 10.1007/s10096-019-03503-4. 2019
Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts
Bassetti M; (...); Munoz, P
Article. 10.1186/s13054-020-2793-y. 2020
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
Escudero-Sanchez, Rosa; (...); Cobo Reinoso, Javier
Article. 10.1093/jac/dkac106. 2022
First case of renal abscess by Parvimonas micra
Garrido-Jareno, M; (...); Lopez-Hontangas, JL
Letter. 10.1016/j.eimc.2018.03.002. 2019
First Report of a Fatal Septicaemia Case Caused by Vibrio metoecus: A Comprehensive Functional and Genomic Study.
Carmona-Salido H; (...); Amaro C
Article. 10.1093/infdis/jiae481. 2024
Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens.
Ruiz Ramos J, Salavert Lletí M
Article. 2019
Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption
Talavera, Monica; (...); Ramirez, Paula
Letter. 10.1016/j.medin.2023.04.013. 2023
Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption.
Talavera, Monica; (...); Ramirez, Paula
Case Reports. 10.1016/j.medine.2023.05.004. 2023
From MIC creep to MIC decline: Staphylococcus aureus antibiotic susceptibility evolution over the last 4 years
Ruiz J; (...); Ramirez P
Letter. 10.1016/j.cmi.2016.05.007. 2016
From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment
Ramirez P; (...); Torres A
Article. 10.1186/s13054-016-1342-1. 2016
Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; (...); Quindós G
Review. 10.1016/j.riam.2020.07.001. 2020
Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies
Candel, FJ; (...); Peman, J
Review. 10.1016/j.riam.2019.09.001. 2020
Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021-2022
Jacqueline, Camille; (...); Herrera-Leon, Silvia
Article. 10.3201/eid2911.221746. 2023
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Genomic characterization of Citrobacter freundii strains coproducing OXA-48 and VIM-1 carbapenemase enzymes isolated in leukemic patient in Spain
Lalaoui, R; (...); Rolain, JM
Article. 10.1186/s13756-019-0630-3. 2019
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12568. 2017
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units
Article. 10.7399/fh.10935. 2018
Hazardous drugs: new challenges, new opportunities.
Valero García S; (...); Poveda Andrés JL
Article. 10.7399/fh.2016.40.2.10462. 2016
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Hematologic neoplasms: interpreting lung findings in chest computed tomography.
Calvillo Batllés P; (...); Compte Torrero L
Article. 10.1016/j.rx.2015.07.003. 2015
High delayed mortality after the first episode of Clostridium difficile infection
Cozar, A; (...); Cobo, J
Article. 10.1016/j.anaerobe.2019.04.004. 2019
High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous $\beta$-Lactams.
Djukovic, Ana; (...); Ubeda, Carles
Article. 2020
High heterogeneity of multidrug-resistant Enterobacteriaceae fecal levels in hospitalized patients is partially driven by intravenous beta-lactams.
Djukovic A; (...); Ubeda C
Article. 10.1128/AAC.01415-19. 2020
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain.
Xu Y; (...); Comas I
Article. 10.1371/journal.pmed.1002961. 2019
Hip prosthesis infection due to Streptococcus gallolyticus subsp. pasteurianus
Valentín Martín A; (...); López-Hontangas JL
Letter. 10.1016/j.eimc.2015.02.014. 2015
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations
Fernandez-Ruiz, Mario; (...); Aguado, Jose Maria
Article. 10.1016/j.eimc.2024.06.003. 2024
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Fernandez-Ruiz, Mario; (...); Abril, Vicente
Article. 10.1016/j.eimce.2024.07.001. 2024
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
Povoa, Pedro; (...); Kalil, Andre C.
Article. 10.1007/s00134-022-06956-y. 2023
IDENTIFICATION OF TARGETABLE MUTATIONS FOR DIFFERENTIAL MOLECULAR DIAGNOSIS OF UTERINE LEIOMYOMAS VERSUS LEIOMYOSARCOMAS USING NEXT GENERATION SEQUENCING
Mas, A.; (...); Simon, C.
Meeting Abstract. 10.1016/j.fertnstert.2018.07.191. 2018
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1007/s00430-022-00759-0. 2023
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2016.1231405. 2017
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis
Edo Solsona MD; (...); Poveda Andrés JL
Article. 10.2147/PPA.S127508. 2017
IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS
Edo-Solsona, M.; (...); Poveda-Andres, J.
Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016
Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1016/j.jgar.2017.09.019. 2018
Impact of an antimicrobial stewardship program on critical haematological patients.
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.7399/fh.2017.41.4.10709. 2017
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves.
Valdivieso-Martinez, Bernardo; (...); Redon, Josep
Article. 10.2196/53580. 2024
Impact of Long-COVID on Health Care Burden: A Case Control Study
Valdivieso-Martinez, Bernardo; (...); Redon, Josep
Article. 10.3390/jcm12185768. 2023
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1038/tpj.2017.19. 2018
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1097/FPC.0000000000000286. 2017
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
Ruiz J; (...); Aliño SF
Article. 10.3390/ijms160920168. 2015
Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.
Álvarez-Lerma F; (...); Martínez-Alonso M
Article. 10.1016/j.medine.2022.12.002. 2023
Impact of the ?Zero Resistance? program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study
Alvarez-Lerma, Francisco; (...); Martinez-Alonso, Montserrat
Article. 10.1016/j.medin.2022.12.002. 2023
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
In vitro study of antimicrobial activity on Klebsiella Pneumoniae biofilms in endotracheal tubes
Ruiz, J; (...); Ramirez, P
Article. 10.1080/1120009X.2019.1601801. 2019
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; (...); Sanz GF
Article. 10.1007/s00277-019-03744-5. 2019
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis
Montesinos P; (...); Sanz MA
Article. 10.1038/bmt.2015.181. 2015
Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients
Pinana, JL; (...); Navarro, D
Article. 10.1111/tid.13158. 2019
Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.
Chorao, Pedro; (...); Sanz, Jaime
Article. 10.1016/j.jtct.2024.12.006. 2024
Individualised antimicrobial dosing in critically ill patients undergoing continuous renal replacement therapy: focus on total drug clearance
Ruiz, J; (...); Ramirez, P
Article. 10.1136/ejhpharm-2016-001114. 2018
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago
Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016
Infections of the Central Nervous System after Untelated Donor Umbilical Cord Blood Transplantation or Human teukocyte Antigen-Matched Sibling Transplantation
Balaguer Rosello A; (...); Sanz, J
Article. 10.1016/j.bbmt.2016.10.005. 2017
INFECTIONS OF THE CENTRAL NERVOUS SYSTEM IN THE ALOGENIC TRANSPLANTATION OF HEMATOPOYETIC PROGENITORS
Balaguer Rosello, A.; (...); Sanz Caballer, J.
Meeting Abstract. 2018
INFECTIOUS SPONDYLODISCITIS: 7-YEAR ANALYSIS OF CLINICAL AND PROGNOSTIC VARIABLES IN A TERTIARY HOSPITAL
Fragio, J; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2018-eular.7272. 2018
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1186/s13756-019-0484-8. 2019
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2017.1323267. 2017
Influence of environmental conditions and pollution on the incidence of Streptococcus pneumoniae infections.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1183/23120541.00014-2017. 2017
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.
Ruiz J; (...); Poveda JL
Article. 10.23736/S0026-4946.18.04978-2. 2018
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study*
Garnacho-Montero, J; (...); Garcia-Garmendia, JL
Article. 10.1097/CCM.0000000000002867. 2018
Initial experience of use of tolvaptan in critically ill patients with fluid overload
Ruiz-Ramos J; (...); Ramirez P
Article. 10.1111/jcpt.12255. 2015
Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.
Bermejo San José F; (...); Sanromán-Álvarez L
Article. 10.7399/fh.2016.40.5.10180. 2016
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Invasive aspergillosis in critically ill patients
Ramirez, P, Garnacho-Montero, J
Review. 10.1016/j.riam.2018.07.001. 2018
Invasive fungal disease by Candida and other yeasts
Pemán J, Salavert M, Quindós G
Editorial Material. 10.1016/j.riam.2016.03.004. 2016
Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen
Montoro, J; (...); Pinana, JL
Article. 10.1111/ejh.13202. 2019
INVASIVE FUNGAL INFECTION IN ADULT PATIENTS SUBMITTED TO UMBILICAL CORD BLOOD TRANSPLANTATION
Montoro, J.; (...); Pinana, J. L.
Meeting Abstract. 2018
Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015
Perez-Nadales, E; (...); Spanish Fusariosis Study Grp
Article. 10.3201/eid2701.190782. 2021
Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.
Ibáñez-Martínez E; (...); Pemán J
Case Reports. 10.1016/j.riam.2021.06.002. 2021
Invasive yeast infections in severely burned patients
Renau, AI, Garcia-Vidal, C, Salavert, M
Review. 10.1016/j.riam.2016.02.002. 2016
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis
Ramos, JM; (...); Portilla, J
Article. 10.4269/ajtmh.16-0940. 2017
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Javea consensus guidelines for the treatment of Candida peritonitis and other intra-abdominal fungal infections in non-neutropenic critically ill adult patients
Peman, J; (...); Jávea Intra-Abdominal Fungal Infection Group
Article. 10.1016/j.riam.2016.12.001. 2017
Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation.
Bueno F; (...); Navarro D
Article. 10.1111/tid.13507. 2020
Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007_g. 2023
Lack of evidence for infectious SARS-CoV-2 in feces and sewage
Albert, Sandra; (...); Domingo-Calap, Pilar
Article. 10.1007/s10096-021-04304-4. 2021
Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.
Cabanero-Navalon MD; (...); Garcia-Bustos V
Article. 10.3390/biomedicines12102239. 2024
Liquid nitrogen sterility in sperm, oocyte and embryo banking
Botella, IM; (...); Peman, J
Meeting Abstract. 2017
Live donor kidney transplantation. Situation analysis and roadmap.
de la Oliva Valentín M; (...); Domínguez-Gil B
Article. 10.1016/j.nefroe.2022.02.002. 2022
Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome.
Zampieri FG; (...); TAVeM study group
Article. 10.1177/0885066618772498. 2018
Lymphocyte Subpopulations in Community-Acquired Pneumonia: Role of Cell-Mediated Immunity
Mendez, R; (...); Menendez, R
Meeting Abstract. 2018
Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality
Mendez, R; (...); Torres, A
Article. 10.1016/j.jinf.2019.04.006. 2019
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Management of infection and febrile neutropenia in patients with solid cancer
Virizuela JA; (...); Cruz JJ
Article. 10.1007/s12094-015-1442-4. 2016
Management of Infection and Febrile Neutropenia in Patients with Solid Cancer
Aguado, JM; (...); Carratala, J
Review. 10.1016/j.eimc.2015.06.005. 2017
Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU.
Estella, A; (...); Zaragoza, R
Article. 10.1016/j.medine.2021.08.013. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Methods of rapid diagnosis in clinical microbiology: Clinical needs
Vila, J; (...); Bosch, J
Article. 10.1016/j.eimc.2016.11.004. 2017
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
Garcia-Broncano, P; (...); GESIDA 3603b Study Grp
Article. 10.1016/j.jinf.2019.09.020. 2020
MINIMALLY INVASIVE VERSUS OPEN HYSTERECTOMY IN HIGH-RISK ENDOMETRIAL CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
Segarra Vidal, B.; (...); Ramirez, P.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.206. 2021
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intra-abdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
Canton, R; (...); SMART Spain Working Grp
Article. 2019
Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.
Fernandez-Megia, MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.10793. 2018
Monographic: antisepsis in the critical patient Introduction
Ramirez, P., Nuvials, X., Diaz, E.
Editorial Material. 10.1016/j.medin.2018.07.018. 2019
Mucormycosis: Current and future management perspective
Gomez, MTM, Lleti, MS
Article. 10.1016/j.riam.2021.04.003. 2021
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM
Climente Martí M, Poveda Andrés JL, Culebras J
Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
Neurogenic muscle hypertrophy
Garcia-Atienza, EM; (...); Lopez, JLT
Letter. 10.33588/rn.6209.2015489. 2016
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
New evidence in severe pneumonia: meropenem-vaborbactam.
Forteza Guillot, Maria, Martin Cerezuela, Maria, Ramirez, Paula
Article. 10.37201/req/s01.10.2022. 2022
Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency.
Moral Moral, Pedro; (...); Salavert Lleti, Miguel
Article. 10.37201/req/s03.14.2022. 2022
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe
Ruiz Gaitan, Alba Cecilia; (...); Peman, Javier
Article. 10.1016/j.riam.2016.11.002. 2017
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Poveda, JL
Meeting Abstract. 2018
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data
Ruiz-Gaitan, AC; (...); Peman, Javier
Article. 10.1016/j.ijantimicag.2019.02.005. 2019
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)
Perez Elias, MJ; (...); CODAR Study Grp
Article. 10.1093/jac/dkz254. 2019
OUTCOMES FOLLOWING OPEN RADICAL HYSTERECTOMY AFTER IMPLEMENTATION OF AN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM
Agusti, N.; (...); Ramirez, P.
Meeting Abstract. 10.1136/ijgc-2021-ESGO.67. 2021
Papel de cefditoreno en el tratamiento de las infecciones comunitarias de piel y tejidos blandos: revisando la evidencia.
Cabañero-Navalón MD, García-Bustos V, Salavert Lletí M
Review. 10.37201/req/063.2021. 2021
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Parasitic Infections in Hematopoietic Stem Cell Transplantation.
Article. 10.4084/MJHID.2016.035. 2016
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
PHARMACOECONOMIC ANALYSIS OF ANIDULAFUNGIN, MICAFUNGIN, CASPOFUNGIN AND FLUCONAZOLE IN THE TREATMENT OF CANDIDEMIA AND/OR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULT PATIENTS IN SPAIN
Grau S; (...); Rubio-Terrés C
Meeting Abstract. 10.1016/j.jval.2015.09.1961. 2015
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.2174/1389200218666171101124931. 2018
Pharmacogenomics and the treatment of acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Review. 10.2217/pgs-2016-0055. 2016
Pharmacokinetics of Amikacin in Critical Care Patients on Extracorporeal Device
Ruiz-Ramos, J; (...); Castellanos-Ortega, A
Article. 10.1097/MAT.0000000000000689. 2018
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.
Calleja Hernández MÁ; (...); Aragon, B
Article. 10.7399/fh.2017.41.1.10463. 2017
Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)
Querol-Fuentes, F; (...); Bonanad, S
Meeting Abstract. 2017
Pilot evaluation of home delivery programme in haemophilia
Megias-Vericat, JE; (...); Poveda-Andres, JL
Article. 10.1111/jcpt.12718. 2018
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics.
Cancino-Munoz, Irving; (...); Comas, Inaki
Article. 10.7554/eLife.76605. 2022
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis
Megías-Vericat JE; (...); Aliño SF
Letter. 10.1038/tpj.2015.79. 2016
Practical document on the management of hyponatremia in critically ill patients
Porcar, MJB; (...); Herrera-Gutierrez, ME
Article. 10.1016/j.medin.2018.12.002. 2019
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process
Valero, S; (...); Poveda, JL
Article. 10.1016/j.yrtph.2018.03.001. 2018
Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score
Cobo, J; (...); Nosocomial Infection Study Group
Article. 10.1016/j.ijantimicag.2017.09.010. 2018
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Probable cutaneous loxoscelism with mild systemic symptoms: A case report from Spain
Jerusalem, K, Lleti, MS
Review. 10.1016/j.toxicon.2018.10.304. 2018
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS
Megias Vericat, J. E.; (...); Sanz, M. A.
Article. 2015
Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.
Garcia-Bustos V; (...); Lletí MS
Article. 10.1038/s41598-021-90949-2. 2021
Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1097/DSS.0000000000001046. 2017
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
Pinana, JL; (...); Navarro, D
Article. 10.1016/j.jinf.2019.02.009. 2019
Pulmonary invasive fungal disease after community acquire respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients: Results from a prospective observational study
Pinana, Jose; (...); Navarro, David
Meeting Abstract. 2019
Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 2018
Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker
Perez-Alenda, S; (...); Querol, F
Letter. 10.1111/hae.13388. 2018
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Vigon, L; (...); Esteban, H
Article. 10.1038/s41598-019-48592-5. 2019
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.
Escudero-Sánchez R; (...); Cobo J
Article. 10.1007/s15010-020-01567-5. 2021
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015
Gonzalez, J; (...); Cohort Spanish HIV Res Network Co
Article. 10.1016/j.eimc.2019.02.007. 2019
Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.
Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC
Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019
Recommendations for antibiotic selection for severe nosocomial infections
Mensa, Josep; (...); Soriano, Alex
Article. 10.37201/req/126.2021. 2021
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Los-Arcos I; (...); Ruiz-Camps I
Review. 10.1007/s15010-020-01521-5. 2020
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.
Vidal-Cortés P; (...); Zaragoza Crespo R
Practice Guideline. 10.1016/j.medine.2021.11.019. 2022
Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile
Bouza, E; (...); Silva, JT
Article. 2019
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients
Hernandez-Tejedor, A; (...); Herrera-Gutierrez, ME
Article. 10.1016/j.medin.2017.03.004. 2017
Recommendations on the use of azole antifungals in hematology-oncology patients
Azanza, Jose Ramon; (...); Gutierrez, Carlos Duenas
Review. 10.37201/req/013.2023. 2023
Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.
Cuéllar Monreal MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.2017.41.1.10434. 2017
Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies
Javier Candel, Francisco; (...); Cuervo Pinto, Rafael
Review. 10.37201/req/023.2023. 2023
Reply to: "ormothermic regional perfusion - What is the benefit?''
Hessheimer, AJ; (...); Fondevila, C
Letter. 10.1016/j.jhep.2019.04.005. 2019
Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms
Martin-Loeches I; (...); Ferrer M
Article. 10.1016/j.jinf.2014.10.004. 2015
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.
Garcillan, Beatriz; (...); Diaz-Castroverde, Sabela
Article. 10.3390/vaccines10020297. 2022
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.
Babich T; (...); Yahav D
Article. 10.1016/j.ijantimicag.2019.11.004. 2020
Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers
Garcia-Tejedor A; (...); Perales A
Article. 10.1016/j.ejogrb.2015.09.009. 2015
Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry
Calafat, M; (...); Domenech, E
Meeting Abstract. 10.1093/ecco-jcc/jjy222.561. 2019
Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach
Alvarez-del Arco, D; (...); CoRIS
Article. 10.1186/s12905-017-0483-y. 2018
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
Garcia-Marin, Ana Maria; (...); Comas, Inaki
Article. 10.1016/S2666-5247(23)00252-5. 2024
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina
Article. 10.1016/j.ijid.2024.107070. 2024
Safety and Tolerability of More than Six Days of Tedizolid Treatment
Vendrell, MM; (...); Viladomiu, AS
Article. 10.1128/AAC.00356-20. 2020
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Article. 10.1111/ajt.14580. 2018
Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome: Life-Threatening Complications of Anti-TNF-alpha Treatment for Crohn's Disease
Saez-Gonzalez, E; (...); Beltran, B
Letter. 10.1038/s41395-018-0420-1. 2019
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
SEPTIC PARTICIPATION IN CARDIOGENIC SHOCK: EXPOSURE TO BACTERIAL ENDOTOXIN
Ramirez, P; (...); Vila, J
Article. 10.1097/SHK.0000000000000798. 2017
Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study
Fenoll, A; (...); ODIN Study Group
Article. 10.1016/j.vaccine.2018.10.098. 2018
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice
Aguas Peris M; (...); Nos, P
Article. 10.1097/MIB.0000000000001182. 2017
Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
Meeting Abstract. 2017
Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit.
Martín-Cerezuela M; (...); Ramírez-Galleymore P
Article. 10.1186/s13054-023-04347-3. 2023
Silver-embedded screens in the intensive care unit. A new tool to control multi-drug resistant bacterial cross-transmission
Ruiz J; (...); Castellanos Á
Article. 10.1007/s10096-017-2959-y. 2017
Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study)
Carcereny Costa, E.; (...); Provencio Pulla, M.
Meeting Abstract. 10.1016/j.annonc.2020.08.1547. 2020
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)
van Oort, PMP; (...); Martin-Loeches, I
Meeting Abstract. 10.1183/13993003.congress-2018.PA2607. 2018
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia.
van Oort PM; (...); Martin-Loeches I
Article. 10.1183/23120541.00212-2018. 2019
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR)
Bouza, Emilio; (...); Barberan, Jose
Article. 10.37201/req/2065.2020. 2020
Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions
Kostaki, EG; (...); CoRIS
Article. 10.3389/fmicb.2019.00370. 2019
Starkeya nomas sp. nov., a prosthecate and budding bacterium isolated from an immunocompromized patient.
Sahuquillo-Arce JM; (...); López-Hontangas JL
Article. 10.1099/ijsem.0.005805. 2023
Streptococcus agalactiae in childbearing age immigrant women in Comunitat Valenciana (Spain)
Sahuquillo-Arce, JM; (...); Lopez-Hontangas, JL
Article. 10.1038/s41598-020-66811-2. 2020
Study of pediatric invasive pneumococcal disease in the 13-pneumococcal conjugated vaccine era.
Garrido-Jareno, Marta; (...); Peman, Javier
Article. 10.1016/j.diagmicrobio.2024.116532. 2024
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
González-López TJ; (...); González-Porras JR
Article. 10.1002/ajh.23900. 2015
Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice.
Ariceta G; (...); Vara J
Article. 10.1093/ckj/sfae049. 2024
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Systemic Biomarkers in Bronchiectasis Exacerbations: A Comparison Between Hospitalized and Outpatients
Amara Elori, I.; (...); Menendez, R.
Meeting Abstract. 2018
Tedizolid: new data and experiences for clinical practice.
Salavert Lleti, M; (...); Cabanero-Navalon, M D
Article. 10.37201/req/s01.06.2021. 2021
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.3390/jcm12206526. 2023
Textbook outcome in patients with biliary duct injury during cholecystectomy.
Lopez-Lopez V; (...); Robles-Campos R
Article. 10.1016/j.gassur.2024.02.027. 2024
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
Piñana J; (...); Sanz J
Article. 10.1016/j.jinf.2019.12.022. 2020
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The challenge of multiresistant microorganisms.
Vicent C, Ramírez P
Editorial Material. 10.1016/j.medcli.2023.12.004. 2024
The Challenge of Treating Infections Caused by Metallo-ß-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
Hidalgo-Tenorio C; (...); Martínez-Martínez L
Article. 10.1007/s40265-024-02102-8. 2024
The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey.
Piñana JL; (...); Navarro D
Article. 10.1038/s41409-019-0698-7. 2020
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort
Feher, C; (...); Mensa, J
Article. 10.1007/s10096-016-2802-x. 2017
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Lopez, Mariana G.; (...); SeqCOVID-Spain Consortium
Article. 10.1038/s41588-021-00936-6. 2021
The positioning of ceftobiprole in Staphylococcus aureus bacteremia.
Membrillo de Novales FJ; (...); Hidalgo-Tenorio C
Article. 10.1093/cid/ciae123. 2024
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.1186/s13054-024-05224-3. 2024
The threat of the carbapenemase-producing enterobacteriaceae in Spain: Positioning report of the SEIMC study groups, GEIH and GEMARA
Oteo J; (...); Salavert M
Article. 10.1016/j.eimc.2014.02.011. 2014
The treatment of mucormycosis (zygomycosis) in the 21st century
Ruiz Camps I, Salavert Lletí M
Review. 10.1016/j.riam.2018.09.001. 2018
The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation
Hessheimer, AJ; (...); Fondevila, C
Letter. 10.1016/j.jhep.2019.01.004. 2019
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus
Torrent-Farnell, J; (...); Lizan, L
Article. 10.1016/j.healthpol.2018.03.002. 2018
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
Alonso-Navarro, Rodrigo; (...); Soriano, Alex
Article. 10.1186/s12879-023-08222-y. 2023
Time-kill assays of amphotericin B plus anidulafungin against Candida tropicalis biofilms formed on two different biomaterials
Fernandez-Rivero, ME; (...); Canton, E
Article. 10.5301/ijao.5000652. 2018
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.rx.2015.01.008. 2015
Transcriptomic depression of immunological synapse as a signature of ventilator-associated pneumonia
Almansa, R; (...); Martin-Loeches, I
Article. 10.21037/atm.2018.05.12. 2018
Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients.
Martin-Loeches I; (...); Bermejo-Martín JF
Article. 10.1080/14787210.2023.2256979. 2023
Tratamiento y prevención de la viruela del mono.
de la Calle-Prieto F; (...); Membrillo FJ
Article. 10.1016/j.eimc.2022.08.001. 2022
Treatment and prevention of monkeypox
Calle-Prieto, Fernando de la; (...); , TERDDPUGDDIYGDDDDS
Review. 10.1016/j.eimc.2022.08.0010213-005X. 2023
Treatment and prevention of monkeypox.
de la Calle-Prieto, Fernando; (...); Membrillo, Francisco Javier
Article. 10.1016/j.eimce.2022.12.010. 2023
Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.
Viale, Pierluigi; (...); Lodise, Thomas P.
Article. 10.1186/s13613-023-01146-5. 2023
Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment
Montesinos P; (...); Sanz MÁ
Article. 10.1016/j.riam.2014.10.003. 2015
Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysis.
Martin-Loeches I; (...); Artigas A
Article. 10.1186/s40635-015-0062-1. 2015
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Update of the treatment of nosocomial pneumonia in the ICU
Zaragoza, R; (...); Martin-Loeches, I
Review. 10.1186/s13054-020-03091-2. 2020
Update on invasive candidiasis in non-neutropenic critically ill adult patients
Zaragoza R; (...); Pemán J
Review. 10.1016/j.riam.2016.03.001. 2016
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients
García-Robles AA; (...); Poveda JL
Letter. 10.1016/j.jns.2016.04.048. 2016
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
González-Porras JR; (...); González-López TJ
Article. 10.1111/bjh.13266. 2015
Usefulness of guideline recommendations for prognosis in patients with candidemia.
Cuervo G; (...); REIPI, the GEMICOMED (SEIMC) and the Spanish CANDI-Bundle Group
Article. 10.1093/mmy/myy118. 2019
Usefulness of procalcitonin for diagnosing infection in critically ill patients with liver cirrhosis
Villarreal E; (...); Ramírez P
Article. 10.1016/j.medin.2015.02.006. 2016
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients
Rodriguez-Veiga, Rebeca; (...); Sanz, Miguel A.
Article. 10.1111/myc.12891. 2019
Validation of a risk score for post-engraftment invasive fungal disease in 414 adult allogeneic hematopoietic stem cell transplant recipients
Montesinos, P.; (...); Sanz, M. A.
Meeting Abstract. 2016
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia
Ruiz, J; (...); Castellanos-Ortega, A
Article. 10.1016/j.jgar.2018.03.007. 2018
Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative
Ruiz-Ramos, J; (...); Castellanos-Ortega, A
Article. 10.1136/ejhpharm-2018-001664. 2020
VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naive HIV-Infected Patients
Jimenez-Sousa, MA; (...); LTNPs Cohort
Article. 10.3390/jcm8030311. 2019
Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1007/s10096-017-2970-3. 2017
VERTEBRAL OSTEOMYELITIS IN THE IMMUNOSUPPRESSED PATIENTS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6621. 2019
Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients
Gil, JJF; (...); Ivorra, JAR
Article. 10.1016/j.medcli.2019.12.029. 2020
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
Santos JR; (...); Clotet B
Article. 10.1093/jac/dkv205. 2015
Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identifying respiratory bacterial pathogens: a fast and efficient method
López-Fabal MF; (...); Regodón M
Article. 2015
What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.
Garcia-Bustos V; (...); Pemán J
Article. 10.3390/microorganisms9102177. 2021
Whether to make decisions "on the fly" regarding treatment for SARS-CoV-2 infection
de Medrano, VAL, de Lucas, EM, Lleti, MS
Letter. 10.1016/j.rce.2020.04.004. 2020
Análisis Epidemiológico, Clínico Y Microbiológico Del Brote De Candidiasis Invasora Por Candida Auris En El Hospital Universitario Y Politécnico La Fe
Autor/es: Alba Cecilia Ruiz Gaitán
Tesis Doctoral
Director/es: JAVIER PEMÁN GARCÍA; PAULA RAMÍREZ GALLEYMORE
Fisiopatogenia Y Diagnóstico De La Ventriculitis Asociada A Drenaje Ventricular Externo
Autor/es: Mónica Gordón Sahuquillo
Tesis Doctoral
Director/es: PAULA RAMÍREZ GALLEYMORE; PAULA RAMÍREZ GALLEYMORE; Soriano A